NCT03886753 Pharmacokinetic (PK) and Pharmacodynamics (PD) Study of Ilera Specific Products Status TERMINATED Phase N/A
NCT03537807 Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS) Status NO_LONGER_AVAILABLE Phase N/A
NCT03520517 Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS Status COMPLETED Phase PHASE1
NCT03506425 A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS) Status COMPLETED Phase PHASE1/PHASE2
NCT03472950 Safety and Efficacy of Ranolazine for the Treatment of Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT03457753 Riluzole Oral Soluble Film Safety and Tolerability in Amyotrophic Lateral Sclerosis Status WITHDRAWN Phase PHASE2
NCT03373981 Non-invasive Brain Stimulation for the Treatment of Depression Symptoms in ALS Status TERMINATED Phase NA
NCT03366506 Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS) Status RECRUITING Phase N/A
NCT03324399 A Study of Protein Metabolism, Microbiome and Investigational Probiotic Use in Patients With ALS Status COMPLETED Phase NA
NCT03272503 A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS) Status UNKNOWN Phase PHASE2
NCT03268603 Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03214224 Remote Pulmonary Function Testing in Amyotrophic Lateral Sclerosis (Pilot) Status COMPLETED Phase NA
NCT03019419 Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2